Genmab A/SGMABNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank93
3Y CAGR+4.1%
5Y CAGR+5.2%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+4.1%/yr
vs +38.7%/yr prior
5Y CAGR
+5.2%/yr
Consistent
Acceleration
-34.7pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.14B | -21.7% |
| 2024 | $7.84B | +80.2% |
| 2023 | $4.35B | -20.2% |
| 2022 | $5.45B | +84.4% |
| 2021 | $2.96B | -37.9% |
| 2020 | $4.76B | +119.7% |
| 2019 | $2.17B | +47.1% |
| 2018 | $1.47B | +33.4% |
| 2017 | $1.10B | -7.0% |
| 2016 | $1.19B | - |